Schering-Plough
SGP
#544
Rank
NZ$77.60 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Market capitalization of Schering-Plough (SGP.defunct.2009)

All time high intraday market cap: NZ$89.52 Billion (April 12, 1999)

Last known market cap: NZ$77.60 Billion

On October 2, 2009 Schering-Plough had a market cap of NZ$77.60 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Schering-Plough from 1997 to 2009

End of year Market Cap

Year Marketcap Change
2009NZ$63.59 B33.26%
2008NZ$47.72 B-15.28%
2007NZ$56.33 B13.23%
2006NZ$49.74 B10.35%
2005NZ$45.08 B4.61%
2004NZ$43.09 B9.63%
2003NZ$39.30 B-36.81%
2002NZ$62.21 B-50.73%
2001NZ$126.25 B-32.56%
2000NZ$187.22 B57.18%
1999NZ$119.12 B-22.83%
1998NZ$154.35 B96.93%
1997NZ$78.38 B